Literature DB >> 32594802

Neuronal Networks in Hypertension: Recent Advances.

Patrice G Guyenet1, Ruth L Stornetta1, George M P R Souza1, Stephen B G Abbott1, Virginia L Brooks2.   

Abstract

Neurogenic hypertension is associated with excessive sympathetic nerve activity to the kidneys and portions of the cardiovascular system. Here we examine the brain regions that cause heightened sympathetic nerve activity in animal models of neurogenic hypertension, and we discuss the triggers responsible for the changes in neuronal activity within these regions. We highlight the limitations of the evidence and, whenever possible, we briefly address the pertinence of the findings to human hypertension. The arterial baroreflex reduces arterial blood pressure variability and contributes to the arterial blood pressure set point. This set point can also be elevated by a newly described cerebral blood flow-dependent and astrocyte-mediated sympathetic reflex. Both reflexes converge on the presympathetic neurons of the rostral medulla oblongata, and both are plausible causes of neurogenic hypertension. Sensory afferent dysfunction (reduced baroreceptor activity, increased renal, or carotid body afferent) contributes to many forms of neurogenic hypertension. Neurogenic hypertension can also result from activation of brain nuclei or sensory afferents by excess circulating hormones (leptin, insulin, Ang II [angiotensin II]) or sodium. Leptin raises blood vessel sympathetic nerve activity by activating the carotid bodies and subsets of arcuate neurons. Ang II works in the lamina terminalis and probably throughout the brain stem and hypothalamus. Sodium is sensed primarily in the lamina terminalis. Regardless of its cause, the excess sympathetic nerve activity is mediated to some extent by activation of presympathetic neurons located in the rostral ventrolateral medulla or the paraventricular nucleus of the hypothalamus. Increased activity of the orexinergic neurons also contributes to hypertension in selected models.

Entities:  

Keywords:  baroreflex; carotid body; hypothalamus; leptin; medulla oblongata

Year:  2020        PMID: 32594802      PMCID: PMC7347452          DOI: 10.1161/HYPERTENSIONAHA.120.14521

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  190 in total

1.  Descending vasomotor pathways from the dorsomedial hypothalamic nucleus: role of medullary raphe and RVLM.

Authors:  J Horiuchi; R M McAllen; A M Allen; S Killinger; M A P Fontes; R A L Dampney
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2004-06-17       Impact factor: 3.619

2.  Carotid body size on CTA: correlation with comorbidities.

Authors:  J A Cramer; R H Wiggins; M Fudim; Z J Engelman; P A Sobotka; L M Shah
Journal:  Clin Radiol       Date:  2013-10-22       Impact factor: 2.350

Review 3.  Sympathetic activity in obesity: a brief review of methods and supportive data.

Authors:  Gavin W Lambert; Markus P Schlaich; Nina Eikelis; Elisabeth A Lambert
Journal:  Ann N Y Acad Sci       Date:  2019-07-03       Impact factor: 5.691

4.  Influence of amygdala lesions on cardiovascular responses to alerting stimuli, on behaviour and on blood pressure development in spontaneously hypertensive rats.

Authors:  B Folkow; M Hallbäck-Nordlander; J Martner; C Nordborg
Journal:  Acta Physiol Scand       Date:  1982-10

5.  Inspiratory modulation of sympathetic activity is increased in female rats exposed to chronic intermittent hypoxia.

Authors:  George Miguel P R Souza; Leni G H Bonagamba; Mateus R Amorim; Davi J A Moraes; Benedito H Machado
Journal:  Exp Physiol       Date:  2016-10-17       Impact factor: 2.969

6.  Respiratory modulation of muscle sympathetic nerve activity in obstructive sleep apnoea.

Authors:  Rania Fatouleh; David K McKenzie; Vaughan G Macefield
Journal:  Exp Physiol       Date:  2014-05-30       Impact factor: 2.969

7.  Carotid Body Ablation Abrogates Hypertension and Autonomic Alterations Induced by Intermittent Hypoxia in Rats.

Authors:  Rodrigo Del Rio; David C Andrade; Claudia Lucero; Paulina Arias; Rodrigo Iturriaga
Journal:  Hypertension       Date:  2016-07-05       Impact factor: 10.190

8.  Acute reductions in blood flow restricted to the dorsomedial medulla induce a pressor response in rats.

Authors:  Hidefumi Waki; Mohammad E R Bhuiyan; Sabine S Gouraud; Miwa Takagishi; Atsutoshi Hatada; Akira Kohsaka; Julian F R Paton; Masanobu Maeda
Journal:  J Hypertens       Date:  2011-08       Impact factor: 4.844

Review 9.  Mechanisms Responsible for Genetic Hypertension in Schlager BPH/2 Mice.

Authors:  Kristy L Jackson; Geoffrey A Head; Cindy Gueguen; Emily R Stevenson; Kyungjoon Lim; Francine Z Marques
Journal:  Front Physiol       Date:  2019-10-18       Impact factor: 4.566

10.  Orexin Receptor Blockade-Induced Sleep Preserves the Ability to Wake in the Presence of Threat in Mice.

Authors:  Shouhei Iwakawa; Yuichi Kanmura; Tomoyuki Kuwaki
Journal:  Front Behav Neurosci       Date:  2019-01-08       Impact factor: 3.558

View more
  13 in total

1.  Activation of the Organum Vasculosum of the Lamina Terminalis Produces a Sympathetically Mediated Hypertension.

Authors:  Sean D Stocker; Megan M Wenner; William B Farquhar; Kirsteen N Browning
Journal:  Hypertension       Date:  2021-11-23       Impact factor: 10.190

2.  TLR4 and AT1R mediate blood-brain barrier disruption, neuroinflammation, and autonomic dysfunction in spontaneously hypertensive rats.

Authors:  Francesca E Mowry; Sarah C Peaden; Javier E Stern; Vinicia C Biancardi
Journal:  Pharmacol Res       Date:  2021-10-02       Impact factor: 7.658

Review 3.  Gut Microbiome and Neuroinflammation in Hypertension.

Authors:  Elaine M Richards; Jing Li; Bruce R Stevens; Carl J Pepine; Mohan K Raizada
Journal:  Circ Res       Date:  2022-02-03       Impact factor: 17.367

4.  Involvement of Neuropeptide Y within Paraventricular Nucleus in Electroacupuncture Inhibiting Sympathetic Activities in Hypertensive Rats.

Authors:  Qi Zhang; Yingying Tan; Xin Wen; Fangfang Li
Journal:  Int J Hypertens       Date:  2022-01-18       Impact factor: 2.420

Review 5.  Interplay between baroreflex sensitivity, obesity and related cardiometabolic risk factors (Review).

Authors:  Sofia K Konstantinidou; Georgia Argyrakopoulou; Nicholas Tentolouris; Vangelis Karalis; Alexander Kokkinos
Journal:  Exp Ther Med       Date:  2021-11-23       Impact factor: 2.447

6.  Inhibition of Microbiota-dependent Trimethylamine N-Oxide Production Ameliorates High Salt Diet-Induced Sympathetic Excitation and Hypertension in Rats by Attenuating Central Neuroinflammation and Oxidative Stress.

Authors:  Gang Liu; Jiayin Cheng; Tianhao Zhang; Yingxin Shao; Xiangxu Chen; Lihong Han; Ru Zhou; Bin Wu
Journal:  Front Pharmacol       Date:  2022-03-10       Impact factor: 5.810

7.  Spinal cord injury impairs cardiac function due to impaired bulbospinal sympathetic control.

Authors:  Mary P M Fossey; Shane J T Balthazaar; Jordan W Squair; Alexandra M Williams; Malihe-Sadat Poormasjedi-Meibod; Tom E Nightingale; Erin Erskine; Brian Hayes; Mehdi Ahmadian; Garett S Jackson; Diana V Hunter; Katharine D Currie; Teresa S M Tsang; Matthias Walter; Jonathan P Little; Matt S Ramer; Andrei V Krassioukov; Christopher R West
Journal:  Nat Commun       Date:  2022-03-16       Impact factor: 14.919

Review 8.  The application of acupuncture in cardiopathy: A bibliometric analysis based on Web of Science across ten recent years.

Authors:  Xiao Li; Zihan Yin; Fayang Ling; Qianhua Zheng; Xiang Li; Wenchuan Qi; Fanrong Liang
Journal:  Front Cardiovasc Med       Date:  2022-09-06

Review 9.  New insights and advances of sodium-glucose cotransporter 2 inhibitors in heart failure.

Authors:  Juexing Li; Lei Zhou; Hui Gong
Journal:  Front Cardiovasc Med       Date:  2022-09-15

10.  Sleep quality, autonomic dysfunction and renal function in diabetic patients with pre-CKD phase.

Authors:  Manabu Kadoya; Akiko Morimoto; Akio Miyoshi; Miki Kakutani-Hatayama; Kae Kosaka-Hamamoto; Kosuke Konishi; Yoshiki Kusunoki; Takuhito Shoji; Hidenori Koyama
Journal:  Sci Rep       Date:  2021-09-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.